Company news

Rhythm Biosciences Limited news in 2026

Rhythm Biosciences Limited's news releases, calls and decks from 2026, newest first.

View company

Commercial Update-Expansion of ColoSTAT ordering capability

November 4, 2026

RHY Q1 FY27 Update

November 3, 2026

Quarterly Activities Report and Appendix 4C

October 26, 2026

Notice of Annual General Meeting/Proxy Form

October 26, 2026

ColoSTAT Economic Study - Australian Public Health Savings

October 6, 2026

Final Director's Interest Notice - Gavin Fox-Smith

September 30, 2026

FY26 Appendix 4G and Corporate Governance Statement

September 29, 2026

FY26 Annual Report

September 29, 2026

AGM date and closing date for director nominations

September 28, 2026

Board Changes

September 28, 2026

Initial ColoSTAT Assessment in UK opens new market access

September 21, 2026

Initial Director's Interest Notice - Carl Stubbings

August 28, 2026

Initial Director's Interest Notice - Maureen Baker

August 28, 2026

FY26 Appendix 4E & Audited Financial Report

August 27, 2026

Appointment of Non-Executive Directors

August 25, 2026

Notification of cessation of securities - RHY

August 20, 2026

ColoSTAT Commercial Rollout Update

August 19, 2026

Bioshares 2026 Presentation

August 5, 2026

Quarterly Activities Report and Appendix 4C

July 29, 2026

Response to ASX Query Letter

April 14, 2026

First ColoSTAT Clinical Test Sale

March 10, 2026

NATA Accredits ColoSTAT Clinical Testing Service

March 8, 2026

RHY Executes SE Asian Genetype Distribution Agreement

March 3, 2026

Exercise of RHYO Options underwritten for $4.5m to $6.0m

February 24, 2026

Trading Halt

February 22, 2026

Half-Year Financial Report and Appendix 4D

February 18, 2026

Rhythm Bio enters ColoSTAT agreement with 4Cyte Pathology

February 16, 2026

ColoSTAT commercial deployment - First physician enrolled

February 10, 2026

Rhythm Biosciences Signs Manufacturing Agreement

February 2, 2026

Quarterly Activities Report and Appendix 4C

January 22, 2026

Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

January 13, 2026

Decks in 2026